100 related articles for article (PubMed ID: 21855152)
1. Pentraxin 3 as a new biomarker of diastolic dysfunction.
Liu Q; Tu T; Bai Z; Zhou S
Int J Cardiol; 2011 Oct; 152(1):106-7. PubMed ID: 21855152
[No Abstract] [Full Text] [Related]
2. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
Matsubara J; Sugiyama S; Nozaki T; Sugamura K; Konishi M; Ohba K; Matsuzawa Y; Akiyama E; Yamamoto E; Sakamoto K; Nagayoshi Y; Kaikita K; Sumida H; Kim-Mitsuyama S; Ogawa H
J Am Coll Cardiol; 2011 Feb; 57(7):861-9. PubMed ID: 21310324
[TBL] [Abstract][Full Text] [Related]
3. Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker.
Ishihara T; Haraguchi G; Kamiishi T; Tezuka D; Inagaki H; Isobe M
J Am Coll Cardiol; 2011 Apr; 57(16):1712-3. PubMed ID: 21492771
[No Abstract] [Full Text] [Related]
4. PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis.
Nebuloni M; Pasqualini F; Zerbi P; Lauri E; Mantovani A; Vago L; Garlanda C
Cardiovasc Pathol; 2011; 20(1):e27-35. PubMed ID: 20356766
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.
Mauri T; Coppadoro A; Bellani G; Bombino M; Patroniti N; Peri G; Mantovani A; Pesenti A
Crit Care Med; 2008 Aug; 36(8):2302-8. PubMed ID: 18596636
[TBL] [Abstract][Full Text] [Related]
6. Mystery of pentraxin-3 not yet resolved: still a long way to its prime time in surgery.
Kunes P; Mandak J; Kolackova M; Krejsek J
Nephrol Dial Transplant; 2009 Mar; 24(3):1064-5; author reply 1065-6. PubMed ID: 19110487
[No Abstract] [Full Text] [Related]
7. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
8. Serial BNP assay in monitoring exercise tolerance in patients with diastolic dysfunction.
Romano S; di Mauro M; Fratini S; Furia N; Ciampini V; Gallina S; Penco M
Int J Cardiol; 2011 Mar; 147(2):312-3. PubMed ID: 21215475
[No Abstract] [Full Text] [Related]
9. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
Parekh N; Maisel AS
Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
[TBL] [Abstract][Full Text] [Related]
10. Polishing the diastolic dysfunction measurement stick.
Handoko ML; Paulus WJ
Eur J Echocardiogr; 2008 Sep; 9(5):575-7. PubMed ID: 18579489
[No Abstract] [Full Text] [Related]
11. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
12. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
Masson S; Aleksova A; Favero C; Staszewsky L; Bernardinangeli M; Belvito C; Cioffi G; Sinagra G; Mazzone C; Bertocchi F; Vago T; Peri G; Cuccovillo I; Masuda N; Barlera S; Mantovani A; Maggioni AP; Franzosi MG; Disertori M; Latini R;
Heart; 2010 Dec; 96(23):1909-14. PubMed ID: 20965978
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats.
Junhong W; Jing Y; Jizheng M; Shushu Z; Xiangjian C; Hengfang W; Di Y; Jinan Z
Int J Cardiol; 2008 Jul; 127(2):198-207. PubMed ID: 17659790
[TBL] [Abstract][Full Text] [Related]
14. Novel strategies in diastolic heart failure.
Paulus WJ
Heart; 2010 Jul; 96(14):1147-53. PubMed ID: 20610461
[No Abstract] [Full Text] [Related]
15. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
[TBL] [Abstract][Full Text] [Related]
17. Effects of CPAP on inflammation in patients with obstructive sleep apnea: is it a matter of time or a matter of marker?
Drager LF; Bortolotto LA; Lorenzi-Filho G
Am J Hypertens; 2011 Apr; 24(4):379-80. PubMed ID: 21423132
[No Abstract] [Full Text] [Related]
18. Heart failure: pentraxin 3—a marker of diastolic dysfunction and HF?
Kaess BM; Vasan RS
Nat Rev Cardiol; 2011 May; 8(5):246-8. PubMed ID: 21448138
[TBL] [Abstract][Full Text] [Related]
19. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
20. Biomarker screening for cardiac dysfunction: the more the merrier?
Tang WH
Am Heart J; 2006 Jul; 152(1):1-3. PubMed ID: 16824825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
